The invention refers to a pharmaceutical or nutraceutical composition comprising a core a) comprising an active ingredient and a water insoluble polymer a coating layer b) above the core a) comprising a salt of an alginic acid and a coating layer c) above the coating layer b) comprising an anionic (meth)acrylate copolymer polymerized from a (meth)acrylate monomer mixture comprising 5 75 % by weight in relation to the total weight of the (meth)acrylate monomer mixture of (meth)acrylate monomers with an anionic group wherein the amount of the water insoluble polymer in the core a) is 2 to 20 % by weight in relation to the weight of the core a) and the amount of the salt of an alginic acid in the coating layer b) is 5 to 85 % by weight in relation to the weight of the core a) and the amount of the anionic (meth)acrylate copolymer in the coating layer c) is 10 to 75 % by weight in relation to the weight of the core a) and to the coating layer b).
